Copy of Copy of Copy of Copy of Blank Landscape Template (1) - Made with PosterMyWall (4).

OUR MISSION

Our Friend Christopher is dedicated to improving and inspiring the lives of those affected by brain cancer. We provide essential patient support, drive innovative research, and raise awareness to foster hope and resilience in our community.

Together, we can make a difference in the fight against brain cancer.

JOIN OUR WARRIORS

Are you or a family member battling Glioblastoma or other form a Brain Cancer. Let us know how we can help.

COMMING SOON

HELP US

FIND A CURE & SERVE OTHERS

Help us fight the battle against Glioblastoma and other malignant brain tumors Today!

DONATE TODAY

About Christopher

Christopher Miles was an accomplished student and athlete who graduated from North Gwinnett High School in 2019. One week after his graduation, Christopher suffered a seizure which led to the diagnosis of a stage 4 glioblastoma brain tumor.

Following his diagnosis, Christopher underwent surgery and then 32 days of radiation then went on to attend the Georgia Southern University while managing the affects of chemotherapy. His bravery and determination to live life to the fullest was astounding. Throughout his treatments, Christopher exemplified strength and courage that served as an inspiration to all around him. Christopher's battle ended on May 25th, 2020.

Christopher's life, while short, was eventful. A star on the football field and basketball court, an exceptional student and an amazing friend to all. He will always be remembered by those who loved him by many nicknames; The Deputy, The Tank, The Legend, CMiles, Toph, but most people simply refer to him as Our Friend Christopher.

Christopher was an hero to many, and an inspiration to all.

Supporting Glioblastoma

A Letter from Michele Miles

Supporting organizations that work to eliminate the challenges of glioblastoma is imperative. We are honored to continue supporting critical research of The Glioblastoma Foundation focused on early detection, prevention and immunotherapies that target glioblastoma tumors. We are also thrilled to support the opening of the Glioblastoma's Genomic Testing Center.